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Abstract Somatostatin inhibits glucagon-secretion from pan-
creatic K cells but its underlying mechanism is unknown. In
mouse K cells, we found that somatostatin induced prominent
hyperpolarization by activating a K+ channel, which was
unaffected by tolbutamide but prevented by pre-treating the
cells with pertussis toxin. The K+ channel was activated by
intracellular GTP (with somatostatin), GTPQS or GLQ subunits.
It was thus identified as a G protein-gated K+ (KG) channel.
RT-PCR and immunohistochemical analyses suggested the KG
channel to be composed of Kir3.2c and Kir3.4. This study
identified a novel ionic mechanism involved in somatostatin-
inhibition of glucagon-secretion from pancreatic K cells.
z 1999 Federation of European Biochemical Societies.
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1. Introduction
Various neurotransmitters and hormones are known to in-
hibit secretion of hormones from pancreatic islets: i.e. nor-
adrenaline, somatostatin and galanin inhibit insulin-secretion
from L cells [1], while somatostatin, but neither noradrenaline
nor galanin, inhibits glucagon-secretion from K cells (for re-
view, see [2]). It was shown that noradrenaline, somatostatin,
and galanin hyperpolarize the membrane in L cells and thus
inhibit insulin-secretion [1]. The agonist-induced hyperpolari-
zation in L cells may be mediated by activation of the ATP-
sensitive K (KATP) channel [3^5], although discrepancies ex-
ist regarding the properties of the agonist-activated K chan-
nel in L cell lines and native L cells [6]. On the other hand, to
our knowledge, the ionic mechanism responsible for somato-
statin-inhibition of glucagon-secretion from K cells has not
been determined. Because glucagon released from K cells en-
hances insulin-secretion from L cells, it is important to eluci-
date the mechanisms which regulate glucagon-secretion for
understanding the physiological control of insulin-secretion.
In this study, we have examined the e¡ects of somatostatin
on the electrical activity of pancreatic K cells isolated from
adult mice using the patch clamp technique. We found that in
K cells somatostatin activated a G protein-gated K (KG)
channel via G protein LQ subunits and induced hyperpolariza-
tion of the membrane. RT-PCR and immunohistochemical
analyses of pancreatic islets suggested the KG channel to be
composed of Kir3.2c and Kir3.4. This study for the ¢rst time
identi¢ed a ionic mechanism by which somatostatin inhibits
glucagon-secretion from pancreatic K cells.
2. Materials and methods
2.1. Preparation and culture of islet cells
Pancreatic islets were isolated by the collagenase perfusion method
from adult female DDY mice [7] under deep anesthesia with pento-
barbital (80 mg/kg). Islets were then dissociated by EDTA and dispase
(Godo Shusei Industries, Ltd., Tokyo, Japan) solution. Dissociated
cells were plated onto collagen-coated glass slips and maintained for
1^6 days in RPMI tissue culture medium (Gibco, Gaithersburg, MD,
USA) supplemented with 10% fetal bovine serum and antibiotic-anti-
mycotic (Life Technologies). The cells were grown in 5% CO2 at 37‡C.
2.2. Electrophysiological recordings
Whole cell and single-channel currents of cultured cells were meas-
ured by the patch clamp technique using a patch clamp ampli¢er
(Axon 200A, Axon Instruments, Inc, Foster City, CA, USA). In
whole cell current recording, the bathing solution contained (in
mM): 130 NaCl, 5 KCl, 1.8 CaCl2, 0.53 MgCl2, and 5.5 HEPES-
NaOH, pH 7.4. NaCl was replaced by equimolar KCl in 100 mM
K-containing bathing solution. The pipette solution contained (in
mM): 145 KCl, 3 K2ATP, 4.3 MgCl2, 1 EGTA, 0.1 GTP, and
5 HEPES-KOH, pH 7.3. The pipette solution used for the perforated
patch clamp technique was as follows (in mM): 30 KCl, 110 L-As-
partic Acid, and 5 HEPES (pH was adjusted to 7.3 by adding KOH).
Nystatin (100^200 Wg/ml; Sigma, St. Louis, USA) was also added to
the solution. In single-channel recording, the high K bath solution
contained (in mM): 145 KCl, 2 MgCl2, 5 EGTA, and 5 HEPES-
KOH, pH 7.3, and the pipette solution contained (in mM): 145
KCl, 1 MgCl2, 1 CaCl2, and 5 HEPES-KOH, pH 7.3. LQ subunit of
pertussis toxin-sensitive G proteins was puri¢ed from the bovine brain
as described [8] and stored at 380‡C. Data were stored on video tapes
using a PCM data recording system and subsequently replayed for
computer analysis. Data were expressed as means þ S.E.
2.3. PCR analysis of mRNA
The cDNAs of isolated islet cells were synthesized as described
previously [9]. Primers for PCR reaction were located in nucleotides
357 to 334 and 350 to 372 of mouse insulin cDNA, 14 to 33 and 463
to 482 of mouse glucagon cDNA, 92 to 111 and 327 to 346 of rat
somatostatin cDNA, 435 to 457 and 1078 to 1100 of rat Kir3.1
cDNA, 914 to 933 and 1410 to 1431 of mouse Kir3.2a cDNA, 286
to 313 and 1471 to 1488 of mouse Kir3.2b cDNA, 954 to 973 and
1263 to 1282 of rat Kir3.2c cDNA, 611 to 630 and 1048 to 1067 of
mouse Kir3.3 cDNA, 989 to 1006 and 1276 to 1294 of rat Kir3.4
cDNA. PCR ampli¢cation was performed for 30 cycles of denature
at 94‡C for 45 s, annealing for 1 min, and extension at 72‡C for 1 min
and then at 72‡C for 8 min. The annealing temperature is 55‡C for
Kir3.1, insulin and glucagon, 59‡C for Kir3.2a, 3.2b, 3.2c and soma-
tostatin and 65‡C for Kir3.3. Because the products from the ¢rst PCR
reactions were not enough to be visualized, 2 Wl of the ¢rst PCR
products was used and ampli¢ed with the same primers except for
Kir3.2a and the same condition as in the ¢rst reaction. For Kir3.2a,
the second PCR was performed using the forward primer of 954^973
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of mouse Kir3.2a cDNA. The products were electrophoresed on a 3%
agarose gel.
2.4. Immunohistochemistry
Properties of the polyclonal antibodies for Kir3.1 (aG1C-1),
Kir3.2a (aG2A-5), Kir3.2b (aG2B-2), Kir3.2c (aG2C-3) and Kir3.4
(aG4N-10) were described previously [10]. The polyclonal antibody
for Kir3.3 (aG3) was raised in rabbit against a synthetic peptide
corresponding to the amino acid residues 2^15 (AQENAAFSPG-
SEEP) in the N-terminal region of mouse Kir3.3. The antiserum
(aG3) was puri¢ed as described previously [10]. Female DDY mice
(8 weeks) were anesthetized deeply with pentobarbital (80 mg/kg) and
perfused with PBS and then with 50 ml of 4% paraformaldehyde in
0.1 M sodium phosphate, pH 7.4 (PAF solution). After perfusion,
pancreases were enucleated, ¢xed again with PAF solution for 48 h,
dehydrated with 30% sucrose, and frozen. Sections (10 Wm) were cut
on a cryostat and thaw-mounted on gelatin-coated slides. On the
other hand, cultured cells on glasses were rinsed with PBS and then
¢xed with PAF solution. The samples of tissue sections or cultured
cell preparations were washed with PBS, treated with PBS containing
0.1% Triton X-100 (PBST) and goat serum and then incubated with
each antibody (1:500^1:1000) in PBST with 1% (w/v) bovine serum
albumin at 4‡C overnight. The samples were washed with PBS at
room temperature and visualized with £uorescein isothiocyanate
(FITC)-labeled anti-rabbit or guinea pig IgG (EY Laboratories, San
Mateo, CA, USA) and Texas Red-labeled anti-mouse IgG (Protos
Immunoresearch, San Francisco, CA, USA). The samples were exam-
ined with a confocal microscope (MRC-1024, Bio-Rad, Hertfordshire,
England). For control experiments, antibodies preabsorbed with ex-
cess antigenic peptides were used. In the immunocytochemistry for
cultured cells, the nuclei were visualized using DAPI (Sigma).
3. Results
Isolated single cells and clusters of 3^20 cells were obtained
after culturing dissociated pancreatic islets for 1^6 days. To
identify K and L cells in this preparation, the cells were im-
munostained with anti-insulin (green in Fig. 1Aa) and anti-
glucagon (red in Fig. 1Ab) antibodies. As shown in Fig. 1Aa,
64% (16/25) of clusters contained only insulin-positive L cells.
One or two glucagon-positive cells were detected in the re-
maining clusters. On the other hand, 26.3% (5/19 cells) of
isolated single cells were glucagon-positive (Fig. 1Ab) and
one cell was somatostatin-positive (not shown). The gluca-
gon-positive K cells were V10 Wm in diameter, while the in-
sulin-positive L cells were V15 Wm in diameter. The cell ca-
pacitance of K cells measured electrophysiologically was
3.3 þ 0.2 pF (n = 6), while that of L cells was 5.0 þ 0.6 pF
(n = 6). Because it was reported that only K cells showed spon-
taneous action potentials in glucose-free bathing solution [11^
13], for the patch clamp experiments of K cells we chose iso-
lated single small cells which showed spontaneous action po-
tentials under glucose-free conditions. Furthermore, we con-
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Fig. 1. Hyperpolarization is the response to somatostatin in K cells. A: Photomicrographs illustrating an insulin immunoreactive cluster cell (a,
green) and a single glucagon immunoreactive cell (b, red). The nuclei were stained by DAPI (a, blue). Scale bar: 10 Wm. B: E¡ect of somato-
statin (SS) on electrical activity in K cell recorded with the perforated patch method under current clamp. Somatostatin but not noradrenaline
(NA) inhibited electrical activity in K cell (a). Tolbutamide (500 WM, Tol) did not block hyperpolarization by 100 nM somatostatin (b). Soma-
tostatin (100 nM) had no e¡ect on action potentials in cells pre-treated overnight with pertussis toxin (100 ng/ml) (c). Arrowheads indicate the
zero voltage level. C: Whole cell currents were measured under voltage clamp steps from 3100 to +60 mV with 20 mV steps (number 1 and
2). The pipette solution contained 3 mM ATP and 100 WM GTP. Somatostatin induced tolbutamide insensitive inwardly rectifying currents (a,
number 2). The holding potential was 340 mV. Zero current level is indicated by arrowheads. The I/V curve of the di¡erence current is shown.
RT-PCR was performed upon the recorded cell cDNA using speci¢c primers for insulin, glucagon and somatostatin (b, cell). The cDNAs syn-
thesized from mouse pancreatic islet was used as a control template (b, islet).
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¢rmed the expression of glucagon by RT-PCR in each cell
which had been used for the experiments in this study as
shown in Fig. 1Cb. Cells which did not show spontaneous
action potentials in glucose-free solution and had a resting
potential of V360 mV (n = 20) and depolarized with gener-
ation of spontaneous action potentials when glucose (11 mM)
was added to the bath were identi¢ed as L cells and not
studied further here.
Under perforated patch whole cell current clamp we could
record spontaneous action potentials in K cells (Fig. 1Ba).
When somatostatin (100 nM) was added to the bath, the cells
were hyperpolarized to 367.2 þ 2.3 mV (n = 3) and the spon-
taneous action potentials ceased. After wash-out of somato-
statin, the membrane depolarized gradually to the control
level and the action potentials resumed. Noradrenaline (1
WM) did not a¡ect the membrane potential of the K cell.
The same results were obtained in all three K cells examined.
The somatostatin-induced hyperpolarization in K cells was not
a¡ected by tolbutamide (500 WM), an inhibitor of ATP-sensi-
tive K channels (Fig. 1Bb, n = 3), while that in L cells was
diminished by this drug (not shown). In Fig. 1Bc, the cell was
pre-treated with pertussis toxin, an inhibitor of Gi=o proteins
[14^16]. In the pre-treated K cells (n = 3), although the sponta-
neous action potentials were recorded as in the non-treated
cells, somatostatin did not induce any hyperpolarization nor
inhibit action potential ¢ring.
In Fig. 1C, the e¡ect of somatostatin on the membrane
current of an K cell was examined under whole cell voltage
clamp condition. The bathing solution contained 100 mM K
and the cell was held at 340 mV. A set of two successive
voltage steps (500 ms in duration) to 390 mV and +10 mV
separated by 3 s were applied to the cell every 6.4 s. Soma-
tostatin increased inward currents at the holding potential and
also during the voltage pulses to 390 mV and induced small
outward currents during the steps to +10 mV. Fig. 1Ca-1 and
Ca-2 depict families of membrane currents evoked by voltage
steps to various potentials in control and during application
of somatostatin (100 nM), respectively. The current-voltage
relationship measured at the pulse end of the somatostatin-
induced current is shown in the lower right panel of Fig. 1Ca.
The current exhibited an inwardly rectifying property with a
reversal potential of V310 mV, which is close to the K
equilibrium potential (EK) under these experimental condi-
tions. Noradrenaline (1 WM) and galanin (50 nM) had no
e¡ect in similar experiments (not shown). The identity of the
cell in Fig. 1C as an K cell was con¢rmed by the expression of
glucagon by RT-PCR of the cell cDNA (Fig. 1Cb). The same
results were obtained in all six K cells examined. The inwardly
rectifying K current was not induced by somatostatin in K
cells treated with pertussis toxin (n = 3). These results suggest
that pertussis toxin-sensitive G proteins are involved in soma-
tostatin activation of an inwardly rectifying K channel in K
cells.
We examined the e¡ects of G protein-stimulation on the K
cell-K channel activity (Fig. 2). Somatostatin (100 nM) was
included in the pipette solution. In cell-attached patches, brief
openings of a K channel whose current amplitude was V2
pA at 360 mV were recorded (Fig. 2Aa). Upon formation of
an inside-out patch, the activity of the small K channel dis-
appeared and openings of a large K channel (V5 pA at 360
mV) abruptly appeared (Fig. 2Ab). The large conductance K
channel was probably an ATP-sensitive K channel because
channel openings were reduced when ATP (10 WM) was added
to the bath. The addition of GTP (10 WM) induced openings
of the small conductance K channel (Fig. 2Ac). GTPQS
(10 WM) caused openings of the small conductance K chan-
nel to be sustained in the patch (Fig. 2Ad). The small con-
ductance K channel was also activated irreversibly by adding
the LQ subunits of G proteins puri¢ed from bovine brain to
the bath (Fig. 2B). Therefore, the somatostatin-activated K
channel in pancreatic K cells was identi¢ed as a G protein-
gated K (KG) channel.
Recently four cDNAs of Kir subunits encoding mammalian
KG channels have been isolated. They are designated Kir3.1/
GIRK1 [17,18], Kir3.2/GIRK2 [19], Kir3.3/GIRK3 [19] and
Kir3.4/GIRK4 [20]. Kir3.2 has at least three splicing variants,
i.e. Kir3.2a, Kir3.2b and Kir3.2c [21^23]. Functional KG
channels are believed to be heterotetramers of Kir3.0 sub-
units; neuronal KG channels are composed of Kir3.1 and
Kir3.2 [21], while the cardiac one is composed of Kir3.1 and
Kir3.4 [20]. To examine which Kir3.0 subunits are expressed
in the pancreatic islet cells, we performed RT-PCR and im-
munohistochemistry analyses of Kir3.0 subunits (Fig. 3). Only
the PCR products of Kir3.2c and Kir3.4 were detected in
pancreatic islets, although the products of all Kir3.0 subunits
examined were detected in mouse cerebellum (Fig. 3A). The
cellular distribution of Kir3.0 subunits was examined by im-
munostaining islets using polyclonal antibodies speci¢c to
each subunit [10]. The immunoreactivities of aG2A-5,
aG2C-3 and aG4N-10 antibodies were clearly detected in
the islets, while aG1C-1, aG2B-2 and aG3 immunoreactivity
were not (Fig. 3B). Kir3.2a and Kir3.2c are splicing variants
derived from the same gene and Kir3.2c is 11 amino acid
residues longer than Kir3.2a. The 11 amino acid residues at
the C-terminal tail in Kir3.2c are the only divergent part be-
tween the two clones [10]. Thus, the antibody against Kir3.2a
(aG2A-5) recognizes both Kir3.2a and Kir3.2c, while aG2C-3
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Fig. 2. G protein activators stimulate KG channel in K cell. These
records were obtained from two K cells which showed action poten-
tials when bathed in normal bathing solution without added glu-
cose. The bath solution was then changed to high K solution and
the membrane potential of the cell-attached membrane patch was
voltage-clamped to 360 mV. A: After formation of an inside-out
patch (open arrow), spontaneous KATP channel activity (b) was ob-
served and reduced by the application of ATP. In the presence of
somatostatin in the pipette solution, the application of GTP (c),
GTPQS (d) and LQ subunits of G proteins (B) induced channel open-
ings quite distinct from those of KATP channels.
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antibody reacts with only Kir3.2c [10]. Because Kir3.2a
mRNA was not detected in RT-PCR analysis, the aG2A-5
antibody probably recognized Kir3.2c proteins in the islet.
Consistently, the immunoreactivities of aG2A-5 and aG2C-3
distributed similarly in the peripheral regions of each islet. On
the other hand, the Kir3.4 immunoreactivity (aG4N-10) dis-
tributed di¡usely in all types of islet cells. All of these immu-
noreactivities disappeared when each antibody was preab-
sorbed with respective immunogenic peptide (not shown).
Fig. 3C shows the double staining of aG2C-3 and either
anti-insulin or anti-glucagon antibody. Anti-insulin antibody
detected many of the islet cells except those in the peripheral
region (red in Fig. 3Ca). Because the aG2C-3 immunoreactiv-
ity existed mainly in the cells at peripheral region of the islet
(green in Fig. 3Cb), the merged image did not produce much
yellow signal (Fig. 3Cc). On the other hand, anti-glucagon
antibody stained peripheral cells (red in Fig. 3Cd) similar to
aG2C-3 (green in Fig. 2Ce) and the merged image of anti-
glucagon and aG2C-3 produced prominent yellow signals
(Fig. 3Cf). Thus, pancreatic K cells may express Kir3.2c and
Kir3.4 subunits of KG channels. The remaining green signals
(aG2C-3) in Fig. 3Cf may be due to N cells, since N cells
stained by anti-somatostatin antibody also exhibited aG2C-3
immunoreactivity (not shown).
In Fig. 4A, the currents £owing through the K cell-KG
channel were recorded at various membrane potentials in
the cell-attached patch. Somatostatin (100 nM) was present
in the pipette solution. Short spike-like openings of inward
currents were observed at potentials more negative than 0
mV (= EK in this experimental condition), while only small
outward currents were recorded at potentials more positive
than EK. Fig. 4Ab shows the current-voltage relationship of
the unitary current. The channel exhibited an inwardly recti-
fying property and its unitary conductance in the inward di-
rection was 30.3 þ 0.7 pS (n = 3). The open time histogram at
360 mV could be ¢tted by a single exponential with a time
constant of 0.20 þ 0.02 ms (n = 3).
Because the KG channel in K cells seemed to be composed
of Kir3.2c and Kir3.4, we co-transfected Kir3.2c and Kir3.4
with m2 receptor in HEK293T cells. In the HEK293T cells, we
could record KG channel activity with acetylcholine in the
pipette (Fig. 4Ba). The KG channel showed an inwardly rec-
tifying property and the unitary conductance for inward cur-
rents was 32.6 þ 0.5 pS (n = 3) (Fig. 4Bb). The open time histo-
gram could be ¢tted by a single exponential with a time
constant of 0.28 þ 0.03 ms (n = 3) (Fig. 4Bc). Therefore, the
KG channel recorded in the HEK293T cells co-transfected
with Kir3.2c and Kir3.4 exhibited conductance and kinetic
properties identical to those of the K cell-KG channel.
4. Discussion
Glucagon secreted from K cells strongly stimulates insulin-
secretion from L cells in the mammalian islet of Langerhans.
Therefore, alteration of glucagon-secretion from K cells is an
important element for physiological control of insulin-secre-
tion. Although it is well known that somatostatin released
from N cells inhibits the secretion of glucagon from pancreatic
K cells [2], its underlying mechanism is still unknown. Two
possible mechanisms have been proposed [2] : (1) interference
with second messenger systems and the exocytosis machinery,
or (2) alterations of membrane ion conductances. For the ¢rst
possibility, because somatostatin receptors are coupled to Gi
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Fig. 4. Comparison of properties of KG channels in an K cell (A)
and Kir3.2c/Kir3.4 transfected in HEK293T cells (B). The single
channel current-voltage relationship in the cell-attached patches (a
and b) and open time histogram at the 360 mV membrane poten-
tial (c). The bath solution contained 150 mM K. The pipette solu-
tion contained 100 nM somatostatin (A) or 10 WM acetylcholine
(B). Arrowhead indicates the zero current level.
Fig. 3. Expression and distribution of Kir3.0 subunits in the mouse
islet. A: RT-PCR analysis of six Kir3.0 subunits in an islet isolated
from mouse pancreas. Islet expressed mRNAs of Kir3.2c and
Kir3.4. B, cerebellum; I, islet; N, water. B: Immunohistochemical
analysis of Kir3.0 in the mouse pancreas. Sections (10 Wm) were
stained with a⁄nity-puri¢ed rabbit anti-mouse Kir3.1 antibody
(aG1C-1), anti-mouse Kir3.2a and Kir3.2c common antibody
(aG2A-5), anti-mouse Kir3.3 antibody (aG3) and anti-rat Kir3.4
antibody (aG4N-10), and with a⁄nity-puri¢ed guinea pig anti-
mouse Kir3.2b antibody (aG2B-2) and anti-mouse Kir3.2c antibody
(aG2C-3), followed by FITC-conjugated anti-rabbit or anti-guinea
pig IgG. These photographs were overlaid with the transmission im-
ages. Scale bar: 20 Wm. C: The islet was double-stained with aG2C-
3 (green) and anti-insulin or glucagon antibody (red), followed by
FITC-conjugated anti-guinea pig IgG and Texas Red-labeled anti-
mouse or rabbit IgG. Panels c and f show triple exposures of £uo-
rescent images and transmission image. Scale bar (shown in panel
f): 20 Wm.
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proteins [24], the hormone may inhibit adenylyl cyclase and
reduce cAMP level in K cells. The reduced level of cAMP may
result in a decrease of glucagon-release from K cells. However,
there is no report available in this context. For the second
possibility, this study for the ¢rst time showed that somato-
statin produces a prominent hyperpolarization of K cell mem-
brane and inhibits its spontaneous action potentials. Because
it is known that secretion of glucagon from K cells is induced
mainly by an increase of intracellular Ca2 due to the Ca2
in£ux through L-type Ca2 channels during spontaneous ac-
tion potentials [2], the somatostatin-induced hyperpolarization
and inhibition of spontaneous action potentials would result
in inhibition of glucagon-secretion by preventing activation of
voltage-dependent Ca2 channels. Consistent with this idea, it
was also reported that GABA, co-released with insulin, from
L cells inhibits glucagon-secretion from K cells by activating
GABAA receptor chloride channels [25]. Activation of the
chloride channel resulted in hyperpolarization and cessation
of action potentials, which would stop the Ca2 in£ow across
the membrane. Therefore membrane hyperpolarization would
be a general mechanism for various hormones to decrease
glucagon-secretion from pancreatic K cells. Further studies
using e.g. Ca2-imaging and measurement of hormone-secre-
tion are, however, needed to evaluate the signi¢cance of hy-
perpolarization in regulation of glucagon-release from K cells.
It is also necessary to examine the possible involvement of
interference of second messenger systems and the exocytosis
machinery in agonist-induced inhibition of glucagon-secre-
tion.
RT-PCR and immunostaining analyses indicated that
Kir3.2c and Kir3.4 proteins were expressed in K cells. The
distribution of Kir3.2c was rather restricted to K and N cells,
while Kir3.4 was expressed in all types of islet cells. Although
Kir3.2c was ¢rst cloned from a L cell line, human pancreas or
insulinoma [26^28], it could not form a functional K channel
responding to G protein-stimulation when expressed alone in
mammalian cell lines or in Xenopus oocyte [10,28]. Similarly,
it was also shown that Kir3.4 alone with m2 receptor ex-
pressed in Xenopus oocytes forms a minimal functional cur-
rent with very fast open-close kinetics [29]. Ferrer et al. [28]
showed that co-injection of Kir3.2c and Kir3.4 with m2 re-
ceptors results in prominent expression of carbachol-activated
strong inwardly rectifying currents. Consistently, we could
record a KG channel activity in HEK293T cells co-transfected
with Kir3.2c, Kir3.4 and m2 receptor cDNAs. The conduc-
tance and kinetic properties of the expressed KG channel in
HEK cells were identical to those of the K cell channel acti-
vated by somatostatin. Therefore, it seems likely that the KG
channels in pancreatic K cells are composed of Kir3.2c and
Kir3.4.
In conclusion, this study for the ¢rst time identi¢ed an ionic
mechanism by which somatostatin inhibits glucagon-secretion
from pancreatic K cells. Further studies on regulation of glu-
cagon-secretion are important to elucidate physiological con-
trol of insulin-secretion from L cells.
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